Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
Status:
Completed
Trial end date:
2020-07-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of teduglutide treatment of
children with short bowel syndrome (SBS) who completed the TED-C13-003 study over a long-term
period. It will evaluate how these children fared after the TED-C13-003 study ended. This
study will also offer teduglutide treatment to eligible subjects, regardless of treatment
received in TED-C13-003.